CareerPlanSign in

Director - U.S. Public Policy

Washington, DC, US💼 Full-time💰 $180,000–$180,000🗓 2026-09-24 → 2026-09-26

Core

Develop and execute U.S. public policy strategies to advance market access, coverage, coding, payment, and adoption of medical device and drug portfolios, with a primary focus on CMS reimbursement and Medicare payment systems.

Role type

Director, U.S. Public Policy (Medical Devices and Drugs)

Builds

Policy strategies and advocacy initiatives for medical device and drug reimbursement within Medicare and Medicaid programs.

Domain

Healthcare / Public Policy / Government Affairs

Deliverable

production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work

Required skills

CMS reimbursement policy expertise, Medicare/Medicaid payment systems knowledge, FDA regulatory process understanding, legislative impact analysis, stakeholder relationship building, strategic policy development, advocacy coalition building, executive communication, cross-functional partnership

Preferred skills

Advanced degree (MPH, MPP, JD, PhD, MBA), medical device industry experience, established relationships with CMS/congressional stakeholders, thought leadership in value-based care

Technologies

CMS systems, Medicare/Medicaid frameworks, FDA regulatory tools

Responsibilities

Develop and execute U.S. public policy strategies for device and drug coverage and payment; Lead policy development and advocacy related to CMS reimbursement frameworks; Monitor and analyze CMS policies affecting medical devices; Evaluate proposed legislation and regulations to assess impacts on reimbursement; Represent the organization before federal agencies, policymakers, and key stakeholders; Partner with commercial, market access, and regulatory teams to align policy priorities with business objectives.

Seniority

Director, strategic leadership & cross-functional influence

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.